Global Antimicrobial Peptides Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Antimicrobial Peptides market size is predicted to grow from US$ 5.4 million in 2025 to US$ 7.5 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
LP Information, Inc. (LPI) ' newest research report, the “Antimicrobial Peptides Industry Forecast” looks at past sales and reviews total world Antimicrobial Peptides sales in 2024, providing a comprehensive analysis by region and market sector of projected Antimicrobial Peptides sales for 2025 through 2031. With Antimicrobial Peptides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antimicrobial Peptides industry.
This Insight Report provides a comprehensive analysis of the global Antimicrobial Peptides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antimicrobial Peptides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antimicrobial Peptides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antimicrobial Peptides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antimicrobial Peptides.
This report presents a comprehensive overview, market shares, and growth opportunities of Antimicrobial Peptides market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Antimicrobial Peptides market?
What factors are driving Antimicrobial Peptides market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antimicrobial Peptides market opportunities vary by end market size?
How does Antimicrobial Peptides break out by Type, by Application?
The global Antimicrobial Peptides market size is predicted to grow from US$ 5.4 million in 2025 to US$ 7.5 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
LP Information, Inc. (LPI) ' newest research report, the “Antimicrobial Peptides Industry Forecast” looks at past sales and reviews total world Antimicrobial Peptides sales in 2024, providing a comprehensive analysis by region and market sector of projected Antimicrobial Peptides sales for 2025 through 2031. With Antimicrobial Peptides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antimicrobial Peptides industry.
This Insight Report provides a comprehensive analysis of the global Antimicrobial Peptides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antimicrobial Peptides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antimicrobial Peptides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antimicrobial Peptides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antimicrobial Peptides.
This report presents a comprehensive overview, market shares, and growth opportunities of Antimicrobial Peptides market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Plant Antimicrobial Peptides
- Microbial Antimicrobial Peptides
- Animal Antimicrobial Peptides
- Pharmaceuticals
- Feed Additives
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AnaSpec
- AMP Biotech
- Phoenix Biotech
- Novabiotics
- Chinese Peptide
- Ontores
- GenScript
- Hycult Biotech
- Sunsmile
- Ruixing Biotechnology
- Zhongnong Yingtai Biotechnology
- Glam Technology
- ProteLight Pharmaceutical & Biotechnology
What is the 10-year outlook for the global Antimicrobial Peptides market?
What factors are driving Antimicrobial Peptides market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antimicrobial Peptides market opportunities vary by end market size?
How does Antimicrobial Peptides break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antimicrobial Peptides Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antimicrobial Peptides by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antimicrobial Peptides by Country/Region, 2020, 2024 & 2031
2.2 Antimicrobial Peptides Segment by Type
2.2.1 Plant Antimicrobial Peptides
2.2.2 Microbial Antimicrobial Peptides
2.2.3 Animal Antimicrobial Peptides
2.3 Antimicrobial Peptides Sales by Type
2.3.1 Global Antimicrobial Peptides Sales Market Share by Type (2020-2025)
2.3.2 Global Antimicrobial Peptides Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antimicrobial Peptides Sale Price by Type (2020-2025)
2.4 Antimicrobial Peptides Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Feed Additives
2.4.3 Others
2.5 Antimicrobial Peptides Sales by Application
2.5.1 Global Antimicrobial Peptides Sale Market Share by Application (2020-2025)
2.5.2 Global Antimicrobial Peptides Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antimicrobial Peptides Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antimicrobial Peptides Breakdown Data by Company
3.1.1 Global Antimicrobial Peptides Annual Sales by Company (2020-2025)
3.1.2 Global Antimicrobial Peptides Sales Market Share by Company (2020-2025)
3.2 Global Antimicrobial Peptides Annual Revenue by Company (2020-2025)
3.2.1 Global Antimicrobial Peptides Revenue by Company (2020-2025)
3.2.2 Global Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
3.3 Global Antimicrobial Peptides Sale Price by Company
3.4 Key Manufacturers Antimicrobial Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antimicrobial Peptides Product Location Distribution
3.4.2 Players Antimicrobial Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIMICROBIAL PEPTIDES BY GEOGRAPHIC REGION
4.1 World Historic Antimicrobial Peptides Market Size by Geographic Region (2020-2025)
4.1.1 Global Antimicrobial Peptides Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antimicrobial Peptides Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antimicrobial Peptides Market Size by Country/Region (2020-2025)
4.2.1 Global Antimicrobial Peptides Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antimicrobial Peptides Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antimicrobial Peptides Sales Growth
4.4 APAC Antimicrobial Peptides Sales Growth
4.5 Europe Antimicrobial Peptides Sales Growth
4.6 Middle East & Africa Antimicrobial Peptides Sales Growth
5 AMERICAS
5.1 Americas Antimicrobial Peptides Sales by Country
5.1.1 Americas Antimicrobial Peptides Sales by Country (2020-2025)
5.1.2 Americas Antimicrobial Peptides Revenue by Country (2020-2025)
5.2 Americas Antimicrobial Peptides Sales by Type (2020-2025)
5.3 Americas Antimicrobial Peptides Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antimicrobial Peptides Sales by Region
6.1.1 APAC Antimicrobial Peptides Sales by Region (2020-2025)
6.1.2 APAC Antimicrobial Peptides Revenue by Region (2020-2025)
6.2 APAC Antimicrobial Peptides Sales by Type (2020-2025)
6.3 APAC Antimicrobial Peptides Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antimicrobial Peptides by Country
7.1.1 Europe Antimicrobial Peptides Sales by Country (2020-2025)
7.1.2 Europe Antimicrobial Peptides Revenue by Country (2020-2025)
7.2 Europe Antimicrobial Peptides Sales by Type (2020-2025)
7.3 Europe Antimicrobial Peptides Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antimicrobial Peptides by Country
8.1.1 Middle East & Africa Antimicrobial Peptides Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antimicrobial Peptides Revenue by Country (2020-2025)
8.2 Middle East & Africa Antimicrobial Peptides Sales by Type (2020-2025)
8.3 Middle East & Africa Antimicrobial Peptides Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antimicrobial Peptides
10.3 Manufacturing Process Analysis of Antimicrobial Peptides
10.4 Industry Chain Structure of Antimicrobial Peptides
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antimicrobial Peptides Distributors
11.3 Antimicrobial Peptides Customer
12 WORLD FORECAST REVIEW FOR ANTIMICROBIAL PEPTIDES BY GEOGRAPHIC REGION
12.1 Global Antimicrobial Peptides Market Size Forecast by Region
12.1.1 Global Antimicrobial Peptides Forecast by Region (2026-2031)
12.1.2 Global Antimicrobial Peptides Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antimicrobial Peptides Forecast by Type (2026-2031)
12.7 Global Antimicrobial Peptides Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AnaSpec
13.1.1 AnaSpec Company Information
13.1.2 AnaSpec Antimicrobial Peptides Product Portfolios and Specifications
13.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AnaSpec Main Business Overview
13.1.5 AnaSpec Latest Developments
13.2 AMP Biotech
13.2.1 AMP Biotech Company Information
13.2.2 AMP Biotech Antimicrobial Peptides Product Portfolios and Specifications
13.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AMP Biotech Main Business Overview
13.2.5 AMP Biotech Latest Developments
13.3 Phoenix Biotech
13.3.1 Phoenix Biotech Company Information
13.3.2 Phoenix Biotech Antimicrobial Peptides Product Portfolios and Specifications
13.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Phoenix Biotech Main Business Overview
13.3.5 Phoenix Biotech Latest Developments
13.4 Novabiotics
13.4.1 Novabiotics Company Information
13.4.2 Novabiotics Antimicrobial Peptides Product Portfolios and Specifications
13.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novabiotics Main Business Overview
13.4.5 Novabiotics Latest Developments
13.5 Chinese Peptide
13.5.1 Chinese Peptide Company Information
13.5.2 Chinese Peptide Antimicrobial Peptides Product Portfolios and Specifications
13.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chinese Peptide Main Business Overview
13.5.5 Chinese Peptide Latest Developments
13.6 Ontores
13.6.1 Ontores Company Information
13.6.2 Ontores Antimicrobial Peptides Product Portfolios and Specifications
13.6.3 Ontores Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ontores Main Business Overview
13.6.5 Ontores Latest Developments
13.7 GenScript
13.7.1 GenScript Company Information
13.7.2 GenScript Antimicrobial Peptides Product Portfolios and Specifications
13.7.3 GenScript Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 GenScript Main Business Overview
13.7.5 GenScript Latest Developments
13.8 Hycult Biotech
13.8.1 Hycult Biotech Company Information
13.8.2 Hycult Biotech Antimicrobial Peptides Product Portfolios and Specifications
13.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hycult Biotech Main Business Overview
13.8.5 Hycult Biotech Latest Developments
13.9 Sunsmile
13.9.1 Sunsmile Company Information
13.9.2 Sunsmile Antimicrobial Peptides Product Portfolios and Specifications
13.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sunsmile Main Business Overview
13.9.5 Sunsmile Latest Developments
13.10 Ruixing Biotechnology
13.10.1 Ruixing Biotechnology Company Information
13.10.2 Ruixing Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
13.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ruixing Biotechnology Main Business Overview
13.10.5 Ruixing Biotechnology Latest Developments
13.11 Zhongnong Yingtai Biotechnology
13.11.1 Zhongnong Yingtai Biotechnology Company Information
13.11.2 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
13.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Zhongnong Yingtai Biotechnology Main Business Overview
13.11.5 Zhongnong Yingtai Biotechnology Latest Developments
13.12 Glam Technology
13.12.1 Glam Technology Company Information
13.12.2 Glam Technology Antimicrobial Peptides Product Portfolios and Specifications
13.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Glam Technology Main Business Overview
13.12.5 Glam Technology Latest Developments
13.13 ProteLight Pharmaceutical & Biotechnology
13.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
13.13.2 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
13.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 ProteLight Pharmaceutical & Biotechnology Main Business Overview
13.13.5 ProteLight Pharmaceutical & Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Antimicrobial Peptides Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antimicrobial Peptides Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Plant Antimicrobial Peptides
Table 4. Major Players of Microbial Antimicrobial Peptides
Table 5. Major Players of Animal Antimicrobial Peptides
Table 6. Global Antimicrobial Peptides Sales byType (2020-2025) & (Mg)
Table 7. Global Antimicrobial Peptides Sales Market Share byType (2020-2025)
Table 8. Global Antimicrobial Peptides Revenue byType (2020-2025) & ($ million)
Table 9. Global Antimicrobial Peptides Revenue Market Share byType (2020-2025)
Table 10. Global Antimicrobial Peptides Sale Price byType (2020-2025) & (US$/Mg)
Table 11. Global Antimicrobial Peptides Sale by Application (2020-2025) & (Mg)
Table 12. Global Antimicrobial Peptides Sale Market Share by Application (2020-2025)
Table 13. Global Antimicrobial Peptides Revenue by Application (2020-2025) & ($ million)
Table 14. Global Antimicrobial Peptides Revenue Market Share by Application (2020-2025)
Table 15. Global Antimicrobial Peptides Sale Price by Application (2020-2025) & (US$/Mg)
Table 16. Global Antimicrobial Peptides Sales by Company (2020-2025) & (Mg)
Table 17. Global Antimicrobial Peptides Sales Market Share by Company (2020-2025)
Table 18. Global Antimicrobial Peptides Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
Table 20. Global Antimicrobial Peptides Sale Price by Company (2020-2025) & (US$/Mg)
Table 21. Key Manufacturers Antimicrobial Peptides Producing Area Distribution and Sales Area
Table 22. Players Antimicrobial Peptides Products Offered
Table 23. Antimicrobial Peptides Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Antimicrobial Peptides Sales by Geographic Region (2020-2025) & (Mg)
Table 27. Global Antimicrobial Peptides Sales Market Share Geographic Region (2020-2025)
Table 28. Global Antimicrobial Peptides Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Antimicrobial Peptides Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Antimicrobial Peptides Sales by Country/Region (2020-2025) & (Mg)
Table 31. Global Antimicrobial Peptides Sales Market Share by Country/Region (2020-2025)
Table 32. Global Antimicrobial Peptides Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Antimicrobial Peptides Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 35. Americas Antimicrobial Peptides Sales Market Share by Country (2020-2025)
Table 36. Americas Antimicrobial Peptides Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Antimicrobial Peptides Sales byType (2020-2025) & (Mg)
Table 38. Americas Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 39. APAC Antimicrobial Peptides Sales by Region (2020-2025) & (Mg)
Table 40. APAC Antimicrobial Peptides Sales Market Share by Region (2020-2025)
Table 41. APAC Antimicrobial Peptides Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Antimicrobial Peptides Sales byType (2020-2025) & (Mg)
Table 43. APAC Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 44. Europe Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 45. Europe Antimicrobial Peptides Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Antimicrobial Peptides Sales byType (2020-2025) & (Mg)
Table 47. Europe Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 48. Middle East & Africa Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 49. Middle East & Africa Antimicrobial Peptides Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Antimicrobial Peptides Sales byType (2020-2025) & (Mg)
Table 51. Middle East & Africa Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 52. Key Market Drivers & Growth Opportunities of Antimicrobial Peptides
Table 53. Key Market Challenges & Risks of Antimicrobial Peptides
Table 54. Key IndustryTrends of Antimicrobial Peptides
Table 55. Antimicrobial Peptides Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Antimicrobial Peptides Distributors List
Table 58. Antimicrobial Peptides Customer List
Table 59. Global Antimicrobial Peptides SalesForecast by Region (2026-2031) & (Mg)
Table 60. Global Antimicrobial Peptides RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Antimicrobial Peptides SalesForecast by Country (2026-2031) & (Mg)
Table 62. Americas Antimicrobial Peptides Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Antimicrobial Peptides SalesForecast by Region (2026-2031) & (Mg)
Table 64. APAC Antimicrobial Peptides Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Antimicrobial Peptides SalesForecast by Country (2026-2031) & (Mg)
Table 66. Europe Antimicrobial Peptides RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Antimicrobial Peptides SalesForecast by Country (2026-2031) & (Mg)
Table 68. Middle East & Africa Antimicrobial Peptides RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Antimicrobial Peptides SalesForecast byType (2026-2031) & (Mg)
Table 70. Global Antimicrobial Peptides RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Antimicrobial Peptides SalesForecast by Application (2026-2031) & (Mg)
Table 72. Global Antimicrobial Peptides RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. AnaSpec Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 74. AnaSpec Antimicrobial Peptides Product Portfolios and Specifications
Table 75. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 76. AnaSpec Main Business
Table 77. AnaSpec Latest Developments
Table 78. AMP Biotech Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 79. AMP Biotech Antimicrobial Peptides Product Portfolios and Specifications
Table 80. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 81. AMP Biotech Main Business
Table 82. AMP Biotech Latest Developments
Table 83. Phoenix Biotech Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 84. Phoenix Biotech Antimicrobial Peptides Product Portfolios and Specifications
Table 85. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 86. Phoenix Biotech Main Business
Table 87. Phoenix Biotech Latest Developments
Table 88. Novabiotics Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 89. Novabiotics Antimicrobial Peptides Product Portfolios and Specifications
Table 90. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 91. Novabiotics Main Business
Table 92. Novabiotics Latest Developments
Table 93. Chinese Peptide Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 94. Chinese Peptide Antimicrobial Peptides Product Portfolios and Specifications
Table 95. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 96. Chinese Peptide Main Business
Table 97. Chinese Peptide Latest Developments
Table 98. Ontores Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 99. Ontores Antimicrobial Peptides Product Portfolios and Specifications
Table 100. Ontores Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 101. Ontores Main Business
Table 102. Ontores Latest Developments
Table 103. GenScript Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 104. GenScript Antimicrobial Peptides Product Portfolios and Specifications
Table 105. GenScript Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 106. GenScript Main Business
Table 107. GenScript Latest Developments
Table 108. Hycult Biotech Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 109. Hycult Biotech Antimicrobial Peptides Product Portfolios and Specifications
Table 110. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 111. Hycult Biotech Main Business
Table 112. Hycult Biotech Latest Developments
Table 113. Sunsmile Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 114. Sunsmile Antimicrobial Peptides Product Portfolios and Specifications
Table 115. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 116. Sunsmile Main Business
Table 117. Sunsmile Latest Developments
Table 118. Ruixing Biotechnology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 119. Ruixing Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
Table 120. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 121. Ruixing Biotechnology Main Business
Table 122. Ruixing Biotechnology Latest Developments
Table 123. Zhongnong Yingtai Biotechnology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 124. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
Table 125. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 126. Zhongnong Yingtai Biotechnology Main Business
Table 127. Zhongnong Yingtai Biotechnology Latest Developments
Table 128. GlamTechnology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 129. GlamTechnology Antimicrobial Peptides Product Portfolios and Specifications
Table 130. GlamTechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 131. GlamTechnology Main Business
Table 132. GlamTechnology Latest Developments
Table 133. ProteLight Pharmaceutical & Biotechnology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 134. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
Table 135. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 136. ProteLight Pharmaceutical & Biotechnology Main Business
Table 137. ProteLight Pharmaceutical & Biotechnology Latest Developments
LIST OFFIGURES
Figure 1. Picture of Antimicrobial Peptides
Figure 2. Antimicrobial Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antimicrobial Peptides Sales Growth Rate 2020-2031 (Mg)
Figure 7. Global Antimicrobial Peptides Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antimicrobial Peptides Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antimicrobial Peptides Sales Market Share by Country/Region (2024)
Figure 10. Antimicrobial Peptides Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Plant Antimicrobial Peptides
Figure 12. Product Picture of Microbial Antimicrobial Peptides
Figure 13. Product Picture of Animal Antimicrobial Peptides
Figure 14. Global Antimicrobial Peptides Sales Market Share byType in 2025
Figure 15. Global Antimicrobial Peptides Revenue Market Share byType (2020-2025)
Figure 16. Antimicrobial Peptides Consumed in Pharmaceuticals
Figure 17. Global Antimicrobial Peptides Market: Pharmaceuticals (2020-2025) & (Mg)
Figure 18. Antimicrobial Peptides Consumed inFeed Additives
Figure 19. Global Antimicrobial Peptides Market:Feed Additives (2020-2025) & (Mg)
Figure 20. Antimicrobial Peptides Consumed in Others
Figure 21. Global Antimicrobial Peptides Market: Others (2020-2025) & (Mg)
Figure 22. Global Antimicrobial Peptides Sale Market Share by Application (2024)
Figure 23. Global Antimicrobial Peptides Revenue Market Share by Application in 2025
Figure 24. Antimicrobial Peptides Sales by Company in 2025 (Mg)
Figure 25. Global Antimicrobial Peptides Sales Market Share by Company in 2025
Figure 26. Antimicrobial Peptides Revenue by Company in 2025 ($ millions)
Figure 27. Global Antimicrobial Peptides Revenue Market Share by Company in 2025
Figure 28. Global Antimicrobial Peptides Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Antimicrobial Peptides Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Antimicrobial Peptides Sales 2020-2025 (Mg)
Figure 31. Americas Antimicrobial Peptides Revenue 2020-2025 ($ millions)
Figure 32. APAC Antimicrobial Peptides Sales 2020-2025 (Mg)
Figure 33. APAC Antimicrobial Peptides Revenue 2020-2025 ($ millions)
Figure 34. Europe Antimicrobial Peptides Sales 2020-2025 (Mg)
Figure 35. Europe Antimicrobial Peptides Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Antimicrobial Peptides Sales 2020-2025 (Mg)
Figure 37. Middle East & Africa Antimicrobial Peptides Revenue 2020-2025 ($ millions)
Figure 38. Americas Antimicrobial Peptides Sales Market Share by Country in 2025
Figure 39. Americas Antimicrobial Peptides Revenue Market Share by Country (2020-2025)
Figure 40. Americas Antimicrobial Peptides Sales Market Share byType (2020-2025)
Figure 41. Americas Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 42. United States Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Antimicrobial Peptides Sales Market Share by Region in 2025
Figure 47. APAC Antimicrobial Peptides Revenue Market Share by Region (2020-2025)
Figure 48. APAC Antimicrobial Peptides Sales Market Share byType (2020-2025)
Figure 49. APAC Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 50. China Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 54. India Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Antimicrobial Peptides Sales Market Share by Country in 2025
Figure 58. Europe Antimicrobial Peptides Revenue Market Share by Country (2020-2025)
Figure 59. Europe Antimicrobial Peptides Sales Market Share byType (2020-2025)
Figure 60. Europe Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 61. Germany Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 62.France Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Antimicrobial Peptides Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Antimicrobial Peptides Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 69. Egypt Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Antimicrobial Peptides in 2025
Figure 75. Manufacturing Process Analysis of Antimicrobial Peptides
Figure 76. Industry Chain Structure of Antimicrobial Peptides
Figure 77. Channels of Distribution
Figure 78. Global Antimicrobial Peptides Sales MarketForecast by Region (2026-2031)
Figure 79. Global Antimicrobial Peptides Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Antimicrobial Peptides Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Antimicrobial Peptides Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Antimicrobial Peptides Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Antimicrobial Peptides Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antimicrobial Peptides Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antimicrobial Peptides by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antimicrobial Peptides by Country/Region, 2020, 2024 & 2031
2.2 Antimicrobial Peptides Segment by Type
2.2.1 Plant Antimicrobial Peptides
2.2.2 Microbial Antimicrobial Peptides
2.2.3 Animal Antimicrobial Peptides
2.3 Antimicrobial Peptides Sales by Type
2.3.1 Global Antimicrobial Peptides Sales Market Share by Type (2020-2025)
2.3.2 Global Antimicrobial Peptides Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antimicrobial Peptides Sale Price by Type (2020-2025)
2.4 Antimicrobial Peptides Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Feed Additives
2.4.3 Others
2.5 Antimicrobial Peptides Sales by Application
2.5.1 Global Antimicrobial Peptides Sale Market Share by Application (2020-2025)
2.5.2 Global Antimicrobial Peptides Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antimicrobial Peptides Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antimicrobial Peptides Breakdown Data by Company
3.1.1 Global Antimicrobial Peptides Annual Sales by Company (2020-2025)
3.1.2 Global Antimicrobial Peptides Sales Market Share by Company (2020-2025)
3.2 Global Antimicrobial Peptides Annual Revenue by Company (2020-2025)
3.2.1 Global Antimicrobial Peptides Revenue by Company (2020-2025)
3.2.2 Global Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
3.3 Global Antimicrobial Peptides Sale Price by Company
3.4 Key Manufacturers Antimicrobial Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antimicrobial Peptides Product Location Distribution
3.4.2 Players Antimicrobial Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIMICROBIAL PEPTIDES BY GEOGRAPHIC REGION
4.1 World Historic Antimicrobial Peptides Market Size by Geographic Region (2020-2025)
4.1.1 Global Antimicrobial Peptides Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antimicrobial Peptides Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antimicrobial Peptides Market Size by Country/Region (2020-2025)
4.2.1 Global Antimicrobial Peptides Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antimicrobial Peptides Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antimicrobial Peptides Sales Growth
4.4 APAC Antimicrobial Peptides Sales Growth
4.5 Europe Antimicrobial Peptides Sales Growth
4.6 Middle East & Africa Antimicrobial Peptides Sales Growth
5 AMERICAS
5.1 Americas Antimicrobial Peptides Sales by Country
5.1.1 Americas Antimicrobial Peptides Sales by Country (2020-2025)
5.1.2 Americas Antimicrobial Peptides Revenue by Country (2020-2025)
5.2 Americas Antimicrobial Peptides Sales by Type (2020-2025)
5.3 Americas Antimicrobial Peptides Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antimicrobial Peptides Sales by Region
6.1.1 APAC Antimicrobial Peptides Sales by Region (2020-2025)
6.1.2 APAC Antimicrobial Peptides Revenue by Region (2020-2025)
6.2 APAC Antimicrobial Peptides Sales by Type (2020-2025)
6.3 APAC Antimicrobial Peptides Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antimicrobial Peptides by Country
7.1.1 Europe Antimicrobial Peptides Sales by Country (2020-2025)
7.1.2 Europe Antimicrobial Peptides Revenue by Country (2020-2025)
7.2 Europe Antimicrobial Peptides Sales by Type (2020-2025)
7.3 Europe Antimicrobial Peptides Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antimicrobial Peptides by Country
8.1.1 Middle East & Africa Antimicrobial Peptides Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antimicrobial Peptides Revenue by Country (2020-2025)
8.2 Middle East & Africa Antimicrobial Peptides Sales by Type (2020-2025)
8.3 Middle East & Africa Antimicrobial Peptides Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antimicrobial Peptides
10.3 Manufacturing Process Analysis of Antimicrobial Peptides
10.4 Industry Chain Structure of Antimicrobial Peptides
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antimicrobial Peptides Distributors
11.3 Antimicrobial Peptides Customer
12 WORLD FORECAST REVIEW FOR ANTIMICROBIAL PEPTIDES BY GEOGRAPHIC REGION
12.1 Global Antimicrobial Peptides Market Size Forecast by Region
12.1.1 Global Antimicrobial Peptides Forecast by Region (2026-2031)
12.1.2 Global Antimicrobial Peptides Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antimicrobial Peptides Forecast by Type (2026-2031)
12.7 Global Antimicrobial Peptides Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AnaSpec
13.1.1 AnaSpec Company Information
13.1.2 AnaSpec Antimicrobial Peptides Product Portfolios and Specifications
13.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AnaSpec Main Business Overview
13.1.5 AnaSpec Latest Developments
13.2 AMP Biotech
13.2.1 AMP Biotech Company Information
13.2.2 AMP Biotech Antimicrobial Peptides Product Portfolios and Specifications
13.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AMP Biotech Main Business Overview
13.2.5 AMP Biotech Latest Developments
13.3 Phoenix Biotech
13.3.1 Phoenix Biotech Company Information
13.3.2 Phoenix Biotech Antimicrobial Peptides Product Portfolios and Specifications
13.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Phoenix Biotech Main Business Overview
13.3.5 Phoenix Biotech Latest Developments
13.4 Novabiotics
13.4.1 Novabiotics Company Information
13.4.2 Novabiotics Antimicrobial Peptides Product Portfolios and Specifications
13.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novabiotics Main Business Overview
13.4.5 Novabiotics Latest Developments
13.5 Chinese Peptide
13.5.1 Chinese Peptide Company Information
13.5.2 Chinese Peptide Antimicrobial Peptides Product Portfolios and Specifications
13.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chinese Peptide Main Business Overview
13.5.5 Chinese Peptide Latest Developments
13.6 Ontores
13.6.1 Ontores Company Information
13.6.2 Ontores Antimicrobial Peptides Product Portfolios and Specifications
13.6.3 Ontores Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ontores Main Business Overview
13.6.5 Ontores Latest Developments
13.7 GenScript
13.7.1 GenScript Company Information
13.7.2 GenScript Antimicrobial Peptides Product Portfolios and Specifications
13.7.3 GenScript Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 GenScript Main Business Overview
13.7.5 GenScript Latest Developments
13.8 Hycult Biotech
13.8.1 Hycult Biotech Company Information
13.8.2 Hycult Biotech Antimicrobial Peptides Product Portfolios and Specifications
13.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hycult Biotech Main Business Overview
13.8.5 Hycult Biotech Latest Developments
13.9 Sunsmile
13.9.1 Sunsmile Company Information
13.9.2 Sunsmile Antimicrobial Peptides Product Portfolios and Specifications
13.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sunsmile Main Business Overview
13.9.5 Sunsmile Latest Developments
13.10 Ruixing Biotechnology
13.10.1 Ruixing Biotechnology Company Information
13.10.2 Ruixing Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
13.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ruixing Biotechnology Main Business Overview
13.10.5 Ruixing Biotechnology Latest Developments
13.11 Zhongnong Yingtai Biotechnology
13.11.1 Zhongnong Yingtai Biotechnology Company Information
13.11.2 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
13.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Zhongnong Yingtai Biotechnology Main Business Overview
13.11.5 Zhongnong Yingtai Biotechnology Latest Developments
13.12 Glam Technology
13.12.1 Glam Technology Company Information
13.12.2 Glam Technology Antimicrobial Peptides Product Portfolios and Specifications
13.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Glam Technology Main Business Overview
13.12.5 Glam Technology Latest Developments
13.13 ProteLight Pharmaceutical & Biotechnology
13.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
13.13.2 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
13.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 ProteLight Pharmaceutical & Biotechnology Main Business Overview
13.13.5 ProteLight Pharmaceutical & Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Antimicrobial Peptides Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antimicrobial Peptides Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Plant Antimicrobial Peptides
Table 4. Major Players of Microbial Antimicrobial Peptides
Table 5. Major Players of Animal Antimicrobial Peptides
Table 6. Global Antimicrobial Peptides Sales byType (2020-2025) & (Mg)
Table 7. Global Antimicrobial Peptides Sales Market Share byType (2020-2025)
Table 8. Global Antimicrobial Peptides Revenue byType (2020-2025) & ($ million)
Table 9. Global Antimicrobial Peptides Revenue Market Share byType (2020-2025)
Table 10. Global Antimicrobial Peptides Sale Price byType (2020-2025) & (US$/Mg)
Table 11. Global Antimicrobial Peptides Sale by Application (2020-2025) & (Mg)
Table 12. Global Antimicrobial Peptides Sale Market Share by Application (2020-2025)
Table 13. Global Antimicrobial Peptides Revenue by Application (2020-2025) & ($ million)
Table 14. Global Antimicrobial Peptides Revenue Market Share by Application (2020-2025)
Table 15. Global Antimicrobial Peptides Sale Price by Application (2020-2025) & (US$/Mg)
Table 16. Global Antimicrobial Peptides Sales by Company (2020-2025) & (Mg)
Table 17. Global Antimicrobial Peptides Sales Market Share by Company (2020-2025)
Table 18. Global Antimicrobial Peptides Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
Table 20. Global Antimicrobial Peptides Sale Price by Company (2020-2025) & (US$/Mg)
Table 21. Key Manufacturers Antimicrobial Peptides Producing Area Distribution and Sales Area
Table 22. Players Antimicrobial Peptides Products Offered
Table 23. Antimicrobial Peptides Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Antimicrobial Peptides Sales by Geographic Region (2020-2025) & (Mg)
Table 27. Global Antimicrobial Peptides Sales Market Share Geographic Region (2020-2025)
Table 28. Global Antimicrobial Peptides Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Antimicrobial Peptides Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Antimicrobial Peptides Sales by Country/Region (2020-2025) & (Mg)
Table 31. Global Antimicrobial Peptides Sales Market Share by Country/Region (2020-2025)
Table 32. Global Antimicrobial Peptides Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Antimicrobial Peptides Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 35. Americas Antimicrobial Peptides Sales Market Share by Country (2020-2025)
Table 36. Americas Antimicrobial Peptides Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Antimicrobial Peptides Sales byType (2020-2025) & (Mg)
Table 38. Americas Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 39. APAC Antimicrobial Peptides Sales by Region (2020-2025) & (Mg)
Table 40. APAC Antimicrobial Peptides Sales Market Share by Region (2020-2025)
Table 41. APAC Antimicrobial Peptides Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Antimicrobial Peptides Sales byType (2020-2025) & (Mg)
Table 43. APAC Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 44. Europe Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 45. Europe Antimicrobial Peptides Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Antimicrobial Peptides Sales byType (2020-2025) & (Mg)
Table 47. Europe Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 48. Middle East & Africa Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 49. Middle East & Africa Antimicrobial Peptides Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Antimicrobial Peptides Sales byType (2020-2025) & (Mg)
Table 51. Middle East & Africa Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 52. Key Market Drivers & Growth Opportunities of Antimicrobial Peptides
Table 53. Key Market Challenges & Risks of Antimicrobial Peptides
Table 54. Key IndustryTrends of Antimicrobial Peptides
Table 55. Antimicrobial Peptides Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Antimicrobial Peptides Distributors List
Table 58. Antimicrobial Peptides Customer List
Table 59. Global Antimicrobial Peptides SalesForecast by Region (2026-2031) & (Mg)
Table 60. Global Antimicrobial Peptides RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Antimicrobial Peptides SalesForecast by Country (2026-2031) & (Mg)
Table 62. Americas Antimicrobial Peptides Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Antimicrobial Peptides SalesForecast by Region (2026-2031) & (Mg)
Table 64. APAC Antimicrobial Peptides Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Antimicrobial Peptides SalesForecast by Country (2026-2031) & (Mg)
Table 66. Europe Antimicrobial Peptides RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Antimicrobial Peptides SalesForecast by Country (2026-2031) & (Mg)
Table 68. Middle East & Africa Antimicrobial Peptides RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Antimicrobial Peptides SalesForecast byType (2026-2031) & (Mg)
Table 70. Global Antimicrobial Peptides RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Antimicrobial Peptides SalesForecast by Application (2026-2031) & (Mg)
Table 72. Global Antimicrobial Peptides RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. AnaSpec Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 74. AnaSpec Antimicrobial Peptides Product Portfolios and Specifications
Table 75. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 76. AnaSpec Main Business
Table 77. AnaSpec Latest Developments
Table 78. AMP Biotech Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 79. AMP Biotech Antimicrobial Peptides Product Portfolios and Specifications
Table 80. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 81. AMP Biotech Main Business
Table 82. AMP Biotech Latest Developments
Table 83. Phoenix Biotech Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 84. Phoenix Biotech Antimicrobial Peptides Product Portfolios and Specifications
Table 85. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 86. Phoenix Biotech Main Business
Table 87. Phoenix Biotech Latest Developments
Table 88. Novabiotics Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 89. Novabiotics Antimicrobial Peptides Product Portfolios and Specifications
Table 90. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 91. Novabiotics Main Business
Table 92. Novabiotics Latest Developments
Table 93. Chinese Peptide Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 94. Chinese Peptide Antimicrobial Peptides Product Portfolios and Specifications
Table 95. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 96. Chinese Peptide Main Business
Table 97. Chinese Peptide Latest Developments
Table 98. Ontores Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 99. Ontores Antimicrobial Peptides Product Portfolios and Specifications
Table 100. Ontores Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 101. Ontores Main Business
Table 102. Ontores Latest Developments
Table 103. GenScript Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 104. GenScript Antimicrobial Peptides Product Portfolios and Specifications
Table 105. GenScript Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 106. GenScript Main Business
Table 107. GenScript Latest Developments
Table 108. Hycult Biotech Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 109. Hycult Biotech Antimicrobial Peptides Product Portfolios and Specifications
Table 110. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 111. Hycult Biotech Main Business
Table 112. Hycult Biotech Latest Developments
Table 113. Sunsmile Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 114. Sunsmile Antimicrobial Peptides Product Portfolios and Specifications
Table 115. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 116. Sunsmile Main Business
Table 117. Sunsmile Latest Developments
Table 118. Ruixing Biotechnology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 119. Ruixing Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
Table 120. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 121. Ruixing Biotechnology Main Business
Table 122. Ruixing Biotechnology Latest Developments
Table 123. Zhongnong Yingtai Biotechnology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 124. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
Table 125. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 126. Zhongnong Yingtai Biotechnology Main Business
Table 127. Zhongnong Yingtai Biotechnology Latest Developments
Table 128. GlamTechnology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 129. GlamTechnology Antimicrobial Peptides Product Portfolios and Specifications
Table 130. GlamTechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 131. GlamTechnology Main Business
Table 132. GlamTechnology Latest Developments
Table 133. ProteLight Pharmaceutical & Biotechnology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 134. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolios and Specifications
Table 135. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 136. ProteLight Pharmaceutical & Biotechnology Main Business
Table 137. ProteLight Pharmaceutical & Biotechnology Latest Developments
LIST OFFIGURES
Figure 1. Picture of Antimicrobial Peptides
Figure 2. Antimicrobial Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antimicrobial Peptides Sales Growth Rate 2020-2031 (Mg)
Figure 7. Global Antimicrobial Peptides Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antimicrobial Peptides Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antimicrobial Peptides Sales Market Share by Country/Region (2024)
Figure 10. Antimicrobial Peptides Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Plant Antimicrobial Peptides
Figure 12. Product Picture of Microbial Antimicrobial Peptides
Figure 13. Product Picture of Animal Antimicrobial Peptides
Figure 14. Global Antimicrobial Peptides Sales Market Share byType in 2025
Figure 15. Global Antimicrobial Peptides Revenue Market Share byType (2020-2025)
Figure 16. Antimicrobial Peptides Consumed in Pharmaceuticals
Figure 17. Global Antimicrobial Peptides Market: Pharmaceuticals (2020-2025) & (Mg)
Figure 18. Antimicrobial Peptides Consumed inFeed Additives
Figure 19. Global Antimicrobial Peptides Market:Feed Additives (2020-2025) & (Mg)
Figure 20. Antimicrobial Peptides Consumed in Others
Figure 21. Global Antimicrobial Peptides Market: Others (2020-2025) & (Mg)
Figure 22. Global Antimicrobial Peptides Sale Market Share by Application (2024)
Figure 23. Global Antimicrobial Peptides Revenue Market Share by Application in 2025
Figure 24. Antimicrobial Peptides Sales by Company in 2025 (Mg)
Figure 25. Global Antimicrobial Peptides Sales Market Share by Company in 2025
Figure 26. Antimicrobial Peptides Revenue by Company in 2025 ($ millions)
Figure 27. Global Antimicrobial Peptides Revenue Market Share by Company in 2025
Figure 28. Global Antimicrobial Peptides Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Antimicrobial Peptides Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Antimicrobial Peptides Sales 2020-2025 (Mg)
Figure 31. Americas Antimicrobial Peptides Revenue 2020-2025 ($ millions)
Figure 32. APAC Antimicrobial Peptides Sales 2020-2025 (Mg)
Figure 33. APAC Antimicrobial Peptides Revenue 2020-2025 ($ millions)
Figure 34. Europe Antimicrobial Peptides Sales 2020-2025 (Mg)
Figure 35. Europe Antimicrobial Peptides Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Antimicrobial Peptides Sales 2020-2025 (Mg)
Figure 37. Middle East & Africa Antimicrobial Peptides Revenue 2020-2025 ($ millions)
Figure 38. Americas Antimicrobial Peptides Sales Market Share by Country in 2025
Figure 39. Americas Antimicrobial Peptides Revenue Market Share by Country (2020-2025)
Figure 40. Americas Antimicrobial Peptides Sales Market Share byType (2020-2025)
Figure 41. Americas Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 42. United States Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Antimicrobial Peptides Sales Market Share by Region in 2025
Figure 47. APAC Antimicrobial Peptides Revenue Market Share by Region (2020-2025)
Figure 48. APAC Antimicrobial Peptides Sales Market Share byType (2020-2025)
Figure 49. APAC Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 50. China Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 54. India Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Antimicrobial Peptides Sales Market Share by Country in 2025
Figure 58. Europe Antimicrobial Peptides Revenue Market Share by Country (2020-2025)
Figure 59. Europe Antimicrobial Peptides Sales Market Share byType (2020-2025)
Figure 60. Europe Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 61. Germany Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 62.France Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Antimicrobial Peptides Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Antimicrobial Peptides Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 69. Egypt Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Antimicrobial Peptides Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Antimicrobial Peptides in 2025
Figure 75. Manufacturing Process Analysis of Antimicrobial Peptides
Figure 76. Industry Chain Structure of Antimicrobial Peptides
Figure 77. Channels of Distribution
Figure 78. Global Antimicrobial Peptides Sales MarketForecast by Region (2026-2031)
Figure 79. Global Antimicrobial Peptides Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Antimicrobial Peptides Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Antimicrobial Peptides Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Antimicrobial Peptides Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Antimicrobial Peptides Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Calcium Channel Blocker Market Growth 2025-2031
US$ 3,660.00
January 2025
91 pages
Global Alpha Galactosidase Market Growth 2025-2031
US$ 3,660.00
December 2025
91 pages
